Paradice Investment Management LLC Sells 33,274 Shares of Enhabit, Inc. $EHAB

Paradice Investment Management LLC reduced its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 1.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,736,964 shares of the company’s stock after selling 33,274 shares during the quarter. Enhabit comprises approximately 3.4% of Paradice Investment Management LLC’s holdings, making the stock its 15th largest position. Paradice Investment Management LLC owned about 3.43% of Enhabit worth $16,744,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. 8 Knots Management LLC boosted its position in shares of Enhabit by 12.6% during the first quarter. 8 Knots Management LLC now owns 4,988,718 shares of the company’s stock worth $43,851,000 after acquiring an additional 557,820 shares during the last quarter. Vanguard Group Inc. lifted its stake in Enhabit by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 2,960,343 shares of the company’s stock worth $26,021,000 after purchasing an additional 47,640 shares in the last quarter. Systematic Financial Management LP lifted its stake in Enhabit by 0.8% in the 1st quarter. Systematic Financial Management LP now owns 2,012,036 shares of the company’s stock worth $17,686,000 after purchasing an additional 15,923 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Enhabit by 0.3% during the 2nd quarter. Geode Capital Management LLC now owns 1,182,993 shares of the company’s stock valued at $11,407,000 after purchasing an additional 3,114 shares during the last quarter. Finally, Iron Triangle Partners LP purchased a new position in shares of Enhabit during the first quarter valued at about $10,021,000.

Enhabit Trading Up 2.5%

Shares of EHAB stock opened at $9.03 on Friday. The company has a market cap of $456.96 million, a PE ratio of -36.11 and a beta of 1.69. Enhabit, Inc. has a 1 year low of $6.47 and a 1 year high of $10.90. The stock’s 50 day simple moving average is $8.21 and its two-hundred day simple moving average is $8.39. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.58 and a quick ratio of 1.58.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, November 5th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.05. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The firm had revenue of $263.60 million during the quarter, compared to analysts’ expectations of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Research analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on EHAB. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enhabit in a report on Tuesday. UBS Group reduced their price target on shares of Enhabit from $10.00 to $8.50 and set a “neutral” rating on the stock in a research report on Friday, August 8th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Enhabit currently has a consensus rating of “Hold” and an average price target of $9.00.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.